Showing results (491-500 of 505) with videos related to
Sort By:
Pageof 51
Cell Reports|January 6, 2022
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2Yaochang Yuan, Xiantao Zhang, Ran Chen, et al.Nature|April 10, 2020
Author Correction: Complete biosynthesis of cannabinoids and their unnatural analogues in yeastXiaozhou Luo, Michael A Reiter, Leo d'Espaux, et al.Immunity|January 24, 2023
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activityYingjiao Cao, Yu Li, Xiangyang Wang, et al.Frontiers in Microbiology|May 16, 2022
Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin LFei Yu, Ting Pan, Feng Huang, et al.Frontiers in Bioengineering and Biotechnology|November 4, 2015
Development of a High Throughput Platform for Screening Glycoside Hydrolases Based on Oxime-NIMSKai Deng, Joel M Guenther, Jian Gao, et al.Nature|August 9, 2016
Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infectionRan He, Shiyue Hou, Cheng Liu, et al.Nature|January 7, 2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsKai Deng, Mihaela Pertea, Anthony Rongvaux, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 10, 2022
Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other VariantsRan Chen, Xiantao Zhang, Yaochang Yuan, et al.Eclinicalmedicine|September 20, 2021
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, ChinaYaping Wang, Ruchong Chen, Fengyu Hu, et al.Journal of Food Protection|January 18, 2021
Prevalence of SARS-CoV-2 Contamination on Food Plant Surfaces as Determined by Environmental MonitoringZiwen Ming, Sukkyun Han, Kai Deng, et al.Pageof 51